603387 基蛋生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)6.0478.63711.09821.74420.231
总资产报酬率 ROA (%)4.2565.9807.51014.63813.669
投入资产回报率 ROIC (%)4.8256.8238.65316.94515.956

边际利润分析
销售毛利率 (%)68.92769.22966.36965.06965.580
营业利润率 (%)21.97822.15422.39230.91632.303
息税前利润/营业总收入 (%)19.70818.72318.59428.99631.995
净利润/营业总收入 (%)19.82319.73520.74827.66129.394

收益指标分析
经营活动净收益/利润总额(%)97.351108.32494.241101.44592.781
价值变动净收益/利润总额(%)17.6350.3858.4386.1645.217
营业外收支净额/利润总额(%)-2.053-1.823-0.540-0.585-0.256

偿债能力分析
流动比率 (X)2.3221.9762.1962.5042.908
速动比率 (X)2.1421.7691.9622.2232.598
资产负债率 (%)26.98326.60727.31927.57127.531
带息债务/全部投入资本 (%)19.24518.31120.71320.11021.571
股东权益/带息债务 (%)412.333438.350375.312388.934359.711
股东权益/负债合计 (%)259.956265.502248.386244.750243.824
利息保障倍数 (X)-10.782-6.170-5.055-16.660-142.038

营运能力分析
应收账款周转天数 (天)129.571123.749123.43192.161114.991
存货周转天数 (天)213.432213.013195.100147.557173.221